Dr Reddy's recalls private label heartburn drug; China's Applikon opens new plant

> India's Dr Reddy's Laboratories has recalled 58,656 bottles of its heartburn generic lansoprazole, sold under private label by Walgreens, CVS and others, because of microbial contamination. Announcement

> China's Applikon Biotechnology has opened a new plant in Guangzhou, China, to manufacture drugs for the Chinese market. Release

> A San Diego, CA, pharmacy has been ordered to repay Medicare $1 million after billing it for unapproved cancer drugs it bought through a supplier in Canada and then sold to doctors without letting them know where they came from. Release

> A Johnson & Johnson ($JNJ) Noramco plant in Delaware has been granted foreign trade zone status, providing it with certain tax benefits. Story

> Janssen Research & Development will evaluate Denmark-based Novozymes Biopharma's engineered albumin-based technology for potential drug candidates. Release

And Finally... AstraZeneca ($AZN) has sold its Aderly Park R&D center in the U.K. to a group that intends to use it for a life sciences campus. Story